Your session is about to expire
← Back to Search
Aloe Vera Juice for Mucositis and Esophagitis
Phase 3
Waitlist Available
Led By Daniel Scaperoth, MD
Research Sponsored by Thompson Cancer Survival Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions
No Placebo-Only Group
Pivotal Trial
Summary
This trial is testing aloe vera juice to see if it can help cancer patients who have painful mouth and throat sores from chemotherapy and radiation. The juice is specially processed to avoid stomach issues. It aims to soothe and heal these sores, potentially improving patients' ability to eat and drink without needing treatment breaks. Aloe vera has been studied for its potential to treat various oral conditions, including chemotherapy-induced oral mucositis.
Who is the study for?
This trial is for adults over 18 with certain cancers (like lip, oral cavity, tongue, neck, esophageal) who are undergoing chemotherapy and radiation. They must consent to the study's terms and agree to use contraception. It excludes pregnant or breastfeeding women, those not on chemo and radiation therapy, or with psychiatric conditions affecting compliance.
What is being tested?
The study tests if drinking Aloe Vera juice can help manage mouth sores and throat irritation caused by cancer treatments. Participants will also use other remedies like Magic Mouthwash and salt-baking soda rinse to compare effectiveness.
What are the potential side effects?
Aloe Vera juice may cause digestive issues such as cramps or diarrhea in some people. The other interventions like Magic Mouthwash might lead to taste changes or a burning sensation in the mouth.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Management of Oral Mucositis and Esophagitis
Prevention of Oral Mucositis and Esophagitis
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Cohort 2--Arm 1Experimental Treatment4 Interventions
Aloe Vera Juice + Standard of Care Treatments Drink ¼ cup (2 ounces) of 100% aloe vera juice 3 times per day, 7 days per week as first line treatment, standard of care agents added as needed
Group II: Cohort 1--Arm 1Experimental Treatment4 Interventions
Aloe Vera Juice + Standard of Care Treatments Swish and spit ¼ cup (2 ounces) of 100% aloe vera juice 3 times per day, 7 days per week as first line treatment, standard of care agents added as needed
Group III: Cohort 1--Arm 2Active Control3 Interventions
Standard of Care Treatments Use salt and baking soda rinses, Magic Mouthwash, Carafate, etc.
Group IV: Cohort 2-- Arm 2Active Control3 Interventions
Standard of Care Treatments Use salt and baking soda rinses, Magic Mouthwash, Carafate, etc.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
100% Aloe Vera Juice
2022
Completed Phase 3
~100
Sucralfate
FDA approved
Magic Mouthwash
2022
Completed Phase 3
~180
Sodium bicarbonate
FDA approved
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for mucositis, such as Aloe Vera Juice, work primarily through their anti-inflammatory and healing properties. Aloe Vera Juice helps reduce inflammation and pain, which are significant symptoms of mucositis.
Its healing properties promote tissue regeneration and repair, essential for treating the ulcerations and lesions in the mucosal lining. These mechanisms are crucial as they not only alleviate the painful symptoms but also enhance the healing process, thereby significantly improving the quality of life for mucositis patients.
Find a Location
Who is running the clinical trial?
Thompson Cancer Survival CenterLead Sponsor
3 Previous Clinical Trials
700 Total Patients Enrolled
Daniel Scaperoth, MDPrincipal InvestigatorThompson Cancer Survival Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with cancer in the lips, mouth, tongue, tonsils, throat, neck, esophagus, or chest area.You are 18 years old or older.You have had allergic reactions to substances similar to aloe vera juice.
Research Study Groups:
This trial has the following groups:- Group 1: Cohort 1--Arm 1
- Group 2: Cohort 1--Arm 2
- Group 3: Cohort 2--Arm 1
- Group 4: Cohort 2-- Arm 2
Awards:
This trial has 4 awards, including:- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.